FR3083108B1 - Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau » - Google Patents

Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau » Download PDF

Info

Publication number
FR3083108B1
FR3083108B1 FR1856029A FR1856029A FR3083108B1 FR 3083108 B1 FR3083108 B1 FR 3083108B1 FR 1856029 A FR1856029 A FR 1856029A FR 1856029 A FR1856029 A FR 1856029A FR 3083108 B1 FR3083108 B1 FR 3083108B1
Authority
FR
France
Prior art keywords
oxazolidine
glycoside
skin moisturizer
diones
diones derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1856029A
Other languages
English (en)
Other versions
FR3083108A1 (fr
Inventor
Maria Dalko
Amélie PREVOT-GUEGUINIAT
Marie-Céline FRANTZ
Sébastien DROPSIT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1856029A priority Critical patent/FR3083108B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to JP2020572707A priority patent/JP7282108B2/ja
Priority to EP19732015.3A priority patent/EP3813785A1/fr
Priority to CN201980042765.2A priority patent/CN112312887B/zh
Priority to KR1020207036968A priority patent/KR102594783B1/ko
Priority to PCT/EP2019/066161 priority patent/WO2020002076A1/fr
Priority to US16/973,887 priority patent/US11420960B2/en
Publication of FR3083108A1 publication Critical patent/FR3083108A1/fr
Application granted granted Critical
Publication of FR3083108B1 publication Critical patent/FR3083108B1/fr
Priority to JP2023003305A priority patent/JP2023052368A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Abstract

La présente invention concerne l'utilisation cosmétique à titre d'agent d'hydratation des matières kératiniques, de préférence la peau, d'un ou plusieurs dérivés C-glycosides 5-oxazolidine-2,4-diones répondant à la formule (I) suivante, ainsi que leurs solvates et/ou leurs isomères (optiques, géométriques, tautomères) et/ou leurs sels :
FR1856029A 2018-06-29 2018-06-29 Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau » Active FR3083108B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1856029A FR3083108B1 (fr) 2018-06-29 2018-06-29 Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau »
EP19732015.3A EP3813785A1 (fr) 2018-06-29 2019-06-19 Utilisation de dérivés de 5-oxazolidine-2,4-dione c-glycoside comme hydratant pour la peau
CN201980042765.2A CN112312887B (zh) 2018-06-29 2019-06-19 5-噁唑烷-2,4-二酮c-糖苷衍生物作为保湿剂用于皮肤的用途
KR1020207036968A KR102594783B1 (ko) 2018-06-29 2019-06-19 피부를 위한 보습제로서의 5-옥사졸리딘-2,4-디온 c-글리코시드 유도체의 용도
JP2020572707A JP7282108B2 (ja) 2018-06-29 2019-06-19 皮膚の保湿剤としての５－オキサゾリジン－２，４－ジオンｃ－グリコシド誘導体の使用
PCT/EP2019/066161 WO2020002076A1 (fr) 2018-06-29 2019-06-19 Utilisation de dérivés de 5-oxazolidine-2,4-dione c-glycoside comme hydratant pour la peau
US16/973,887 US11420960B2 (en) 2018-06-29 2019-06-19 Use of 5-oxazolidine-2,4-dione C-glycoside derivatives as moisturizer for the skin
JP2023003305A JP2023052368A (ja) 2018-06-29 2023-01-12 皮膚の保湿剤としての５－オキサゾリジン－２，４－ジオンｃ－グリコシド誘導体の使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1856029A FR3083108B1 (fr) 2018-06-29 2018-06-29 Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau »
FR1856029 2018-06-29

Publications (2)

Publication Number Publication Date
FR3083108A1 FR3083108A1 (fr) 2020-01-03
FR3083108B1 true FR3083108B1 (fr) 2020-05-29

Family

ID=65861321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1856029A Active FR3083108B1 (fr) 2018-06-29 2018-06-29 Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau »

Country Status (7)

Country Link
US (1) US11420960B2 (fr)
EP (1) EP3813785A1 (fr)
JP (2) JP7282108B2 (fr)
KR (1) KR102594783B1 (fr)
CN (1) CN112312887B (fr)
FR (1) FR3083108B1 (fr)
WO (1) WO2020002076A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3376110A (en) 1967-01-30 1968-04-02 Gen Aniline & Film Corp Solid stabilized hydrogen peroxide compositions
US5008093A (en) 1989-11-08 1991-04-16 Gaf Chemicals Corporation Anhydrous complexes of PVP and hydrogen peroxide
US5183901A (en) 1992-01-24 1993-02-02 Isp Investments Inc. Urea-hydrogen peroxide-polyvinylpyrrolidone
FR2818547B1 (fr) 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
EP2123663B1 (fr) * 2007-03-09 2014-08-06 Seikagaku Corporation Procédé de production de dérivé de sucre oxazoline
FR2940611B1 (fr) 2008-12-30 2012-01-13 Oreal Association de monosaccharides et d'adenosine et son utilisation en cosmetique
FR2969149B1 (fr) * 2010-12-16 2012-12-28 Oreal Procede de depigmentation des matieres keratiniques a l' aide de composes derives de resorcinol
WO2013134415A1 (fr) 2012-03-07 2013-09-12 Vertex Pharmaceuticals Incorporated Dérivés de mannose pour le traitement d'infections bactériennes
FR3035787B1 (fr) * 2015-05-07 2018-08-24 L'oreal Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, acides ou ester, et la composition cosmetique les contenant
FR3058417B1 (fr) * 2016-11-07 2019-02-01 L'oreal Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant
CN110114347A (zh) 2016-11-07 2019-08-09 莱雅公司 使用酸、酯或酰胺c-糖苷衍生物以及含有其的化妆品组合物处理角蛋白材料的方法
EP3535250A1 (fr) 2016-11-07 2019-09-11 L'Oréal Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, et la composition cosmetique les contenant
JP6233492B1 (ja) 2016-11-14 2017-11-22 マツダ株式会社 排気浄化装置の再生制御装置
FR3083109B1 (fr) 2018-06-29 2020-05-29 L'oreal Procede de traitement des matieres keratiniques par des composes c-glycosides5-oxazolidine-2,4-diones, composes et composition cosmetique les contenant

Also Published As

Publication number Publication date
JP2023052368A (ja) 2023-04-11
EP3813785A1 (fr) 2021-05-05
US11420960B2 (en) 2022-08-23
KR20210013171A (ko) 2021-02-03
CN112312887B (zh) 2023-06-02
US20210276989A1 (en) 2021-09-09
CN112312887A (zh) 2021-02-02
JP7282108B2 (ja) 2023-05-26
FR3083108A1 (fr) 2020-01-03
JP2021528457A (ja) 2021-10-21
KR102594783B1 (ko) 2023-10-26
WO2020002076A1 (fr) 2020-01-02

Similar Documents

Publication Publication Date Title
UY37847A (es) Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3
UY27516A1 (es) Bencimidazoles
NI200900091A (es) Sales y formas de cristal del 2-metil-2-[4-(3-metil-2-oxo-8-quinolin-3-il-2,3-dihidro-imidazo-[4,5-c]-quinolin-1-il)- fenil]-propionitrilo
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
BRPI0405329A (pt) Composição e processo de tintura das fibras queratìnicas, dispositivo com vários compartimentos, uso para a tintura de oxidação das fibras queratìnicas, derivados de aminon,n-diidro-pirazolona e processos de preparação de um composto
MA30709B1 (fr) Derives de pyrido (2, 3-d) pyrimidinone et leur utilisation comme inhibiteurs de pi3.
DE50115490D1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
NO20050870L (no) Fosfodiesterase 4-inhibitorer, inkludert N-substituerte anilin- og difenylaminanaloger
MA29261B1 (fr) Derives de (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole, leur preparation et leur application en therapeutique
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
MA31903B1 (fr) Derives de thiazole utilises comme inhibiteur de la pi 3 kinase
DE60038252D1 (de) Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3
CU23288B7 (es) DERIVADOS DE TROPANO ÃsTILES EN TERAPIA
ATE302775T1 (de) Carbolinderivate
BR112022013109A2 (pt) Formulações de inibidor de quinase amorfo e métodos de uso das mesmas
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
MA50655B1 (fr) Sels de dérivés de pyrrolotriazine utiles en tant qu'inhibiteurs de tam
ECSP034534A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
AR108461A1 (es) Compuestos imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cáncer
SV2004001549A (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DE60121461D1 (de) Kondensierte pyridoindolderivate
AR056049A1 (es) 2-(2,6-dimetil-morfolin-4-il-n-[5-(6-morfolin-4-il-4-oxo-4h-piran-2-il)-9h-tioxanten-2-il]-acetamida,como inhibidor de la quinasa atm
EA201992090A1 (ru) ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200103

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6